Skip to main content
Signal8

Neuronetics, Inc. (STIM)

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Neuronetics, Inc. logo

Neuronetics, Inc.

NASDAQ:STIMHealthcare
+8.60%$2.33
Mkt Cap$181.5M
Float42.9M
O/S77.73M
VOL1.72M sh
$ Vol$3.65M
RVOL1.50×
Inst Own48.7%
SI16.8%
Dilution
Neuronetics, Inc. logoNASDAQ:STIM$2.33+8.60%
Historical Data
DateOpenHighLowCloseVolume
Nov 9, 20262.232.371.902.331,722,728
Nov 6, 20262.462.562.112.153,664,199
Nov 5, 20262.702.732.412.431,646,093
Nov 4, 20262.773.052.552.715,469,587
Nov 3, 20262.112.272.112.261,828,619
Nov 2, 20262.342.372.042.06976,145
Oct 30, 20262.342.382.152.251,089,348
Oct 29, 20262.272.482.232.38832,299
Oct 28, 20262.182.292.172.26319,224
Oct 27, 20262.242.252.182.19278,262
Oct 26, 20262.132.352.112.241,098,974
Oct 23, 20262.082.172.022.11600,452
Oct 22, 20261.992.101.982.08788,217
Oct 21, 20261.982.021.962.01327,963
Oct 20, 20261.882.021.881.98603,219
Oct 19, 20261.881.941.851.91559,148
Oct 16, 20261.951.971.851.89967,692
Oct 15, 20261.881.991.841.95768,724
Oct 14, 20261.951.971.881.89818,302
Oct 13, 20262.132.131.991.99547,946
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
5
HOLD
2
SELL
0
TOTAL7
Insider Trades
InsiderTypeShares
Chernett Jorey profile photoChernett JoreyPurchase18.0K
Chernett Jorey profile photoChernett JoreyPurchase14.0K
Chernett Jorey profile photoChernett JoreySale100
Naor Nir profile photoNaor NirGrant/Award500.0K
Chernett Jorey profile photoChernett JoreyPurchase35.0K
Amin Avinash profile photoAmin AvinashOther2.9K
Shareholders
48.7%
Institutional
(84)
11.5%
Insiderⓘ
(14)
21.8%
5%+ Owners
(3)
of which 1.9% rests on schedules older than 24 months (1 holder)
18.1%
Unattributed (incl. retail)ⓘ
Institutional48.7%
Insider11.5%
5%+ Beneficial21.8%
Unattributed (incl. retail)18.1%
Sources: 13F, Form 4, 13D/13GO/S: 77.7M · as of 28 Oct 2026 · SEC filings
Insiders & Institutional Holders

Insiders

Top institutional holders

About

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad.

The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.

Key Metrics
Market Cap$181.50M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership48.65%

based on 77.73M shares outstanding

SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
CountryUSUS
IPO DateJun 28, 2018
Shares Outstanding77.73M
Authorized Shares
Float42.90M
52-Week Range
$0.8000$3.44
$2.33(58th percentile)
Volume
Average Daily Volume1.15M
1.72M today vs 1.15M avg(+50%)

30d Avg

1.15M

60d Avg

1.18M

90d Avg

1.25M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...